{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:23Z","timestamp":1787020643721,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Major Research and Development Program","award":["2024YFC27074"],"award-info":[{"award-number":["2024YFC27074"]}]},{"name":"the Industry-Academia-Research Cooperation Science and Technology Education Project of the Ministry of Education","award":["230831502007010"],"award-info":[{"award-number":["230831502007010"]}]},{"name":"the Qingdao Natural Science Foundation","award":["24-4-4-zrjj-159-jch"],"award-info":[{"award-number":["24-4-4-zrjj-159-jch"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08006-3","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:29:38Z","timestamp":1773746978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The small molecule compound ETP-46321 suppresses gastric cancer progression by inducing SAT1-mediated ferroptosis and inhibiting the PI3K\/AKT\/mTOR pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Qingao","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runcheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"8006_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"8006_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8006_CR3","doi-asserted-by":"publisher","first-page":"188615","DOI":"10.1016\/j.bbcan.2021.188615","volume":"1876","author":"K Li","year":"2021","unstructured":"Li K, Zhang A, Li X, Zhang H, Zhao. L. Advances in clinical immunotherapy for gastric cancer. Biochim Biophys Acta Rev Cancer. 2021;1876:188615.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8006_CR4","doi-asserted-by":"publisher","first-page":"e23917","DOI":"10.1016\/j.heliyon.2023.e23917","volume":"10","author":"Y Li","year":"2024","unstructured":"Li Y, et al. MFG-E8 promotes M2 polarization of macrophages and is associated with poor prognosis in patients with gastric cancer. Heliyon. 2024;10:e23917.","journal-title":"Heliyon"},{"key":"8006_CR5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33:1005\u201320.","journal-title":"Ann Oncol"},{"key":"8006_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","volume":"20","author":"M Alsina","year":"2023","unstructured":"Alsina M, Arrazubi V, Diez M, Tabernero J. Current developments in gastric cancer: from molecular profiling to treatment strategy. Nat Rev Gastroenterol Hepatol. 2023;20:155\u201370.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8006_CR7","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71:264\u201379.","journal-title":"CA Cancer J Clin"},{"key":"8006_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.21323\/2618-9771-2024-7-2-312-320","volume":"7","author":"MRT Alifiansyah","year":"2024","unstructured":"Alifiansyah MRT, et al. QSAR of acyl alizarin red biocompound derivatives of Rubia tinctorum roots and its ADMET properties as anti-breast cancer candidates against MMP-9 protein receptor: In Silico study. Food Syst. 2024;7:312\u201320.","journal-title":"Food Syst"},{"key":"8006_CR9","doi-asserted-by":"publisher","first-page":"1281731","DOI":"10.3389\/fendo.2023.1281731","volume":"14","author":"L Scappaticcio","year":"2023","unstructured":"Scappaticcio L, Ansori ANM, Trimboli P, Editorial. Cancer-related hypercalcemia and potential treatments. Front Endocrinol (Lausanne). 2023;14:1281731.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"8006_CR10","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1016\/j.bmcl.2012.03.090","volume":"22","author":"S Mart\u00ednez Gonz\u00e1lez","year":"2012","unstructured":"Mart\u00ednez Gonz\u00e1lez S, et al. Identification of ETP-46321, a potent and orally bioavailable PI3K \u03b1, \u03b4 inhibitor. Bioorg Med Chem Lett. 2012;22:3460\u20136.","journal-title":"Bioorg Med Chem Lett"},{"key":"8006_CR11","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/biomedicines9111639","volume":"9","author":"EJ Sun","year":"2021","unstructured":"Sun EJ, Wankell M, Palamuthusingam P, McFarlane C, Hebbard L. Targeting the PI3K\/Akt\/mTOR Pathway in Hepatocellular Carcinoma. Biomedicines. 2021;9:1639.","journal-title":"Biomedicines"},{"key":"8006_CR12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, et al. The PI3K Pathway in Human Disease. Cell. 2017;170:605\u201335.","journal-title":"Cell"},{"key":"8006_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394.","journal-title":"Semin Cancer Biol"},{"key":"8006_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/biom13010093","volume":"13","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Long H, Zhou Z, Fu Y, Jiang B. PI3K-AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds. Biomolecules. 2023;13:93.","journal-title":"Biomolecules"},{"key":"8006_CR15","doi-asserted-by":"publisher","first-page":"104787","DOI":"10.1016\/j.yexmp.2022.104787","volume":"127","author":"MR Khezri","year":"2022","unstructured":"Khezri MR, Jafari R, Yousefi K, Zolbanin NM. The PI3K\/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions. Exp Mol Pathol. 2022;127:104787.","journal-title":"Exp Mol Pathol"},{"key":"8006_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/cancers12010093","volume":"12","author":"A Alqahtani","year":"2019","unstructured":"Alqahtani A, Ayesh HSK, Halawani H. PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis. Cancers (Basel). 2019;12:93.","journal-title":"Cancers (Basel)"},{"key":"8006_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138.","journal-title":"Mol Cancer"},{"key":"8006_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20:74\u201388.","journal-title":"Nat Rev Cancer"},{"key":"8006_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6:425.","journal-title":"Signal Transduct Target Ther"},{"key":"8006_CR20","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3390\/ijms25031848","volume":"25","author":"D-T Morgos","year":"2024","unstructured":"Morgos D-T, et al. Targeting PI3K\/AKT\/mTOR and MAPK Signaling Pathways in Gastric Cancer. Int J Mol Sci. 2024;25:1848.","journal-title":"Int J Mol Sci"},{"key":"8006_CR21","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s10495-023-01855-z","volume":"28","author":"G Chen","year":"2023","unstructured":"Chen G, et al. Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K\/AKT\/mTOR signal pathway. Apoptosis. 2023;28:1390\u2013405.","journal-title":"Apoptosis"},{"key":"8006_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.canlet.2021.08.020","volume":"520","author":"L Jiang","year":"2021","unstructured":"Jiang L, et al. Bcl2-associated athanogene 4 promotes the invasion and metastasis of gastric cancer cells by activating the PI3K\/AKT\/NF-\u03baB\/ZEB1 axis. Cancer Lett. 2021;520:409\u201321.","journal-title":"Cancer Lett"},{"key":"8006_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10637-012-9835-5","volume":"31","author":"TG Granda","year":"2013","unstructured":"Granda TG, et al. Biological characterization of ETP-46321 a selective and efficacious inhibitor of phosphoinositide-3-kinases. Invest New Drugs. 2013;31:66\u201376.","journal-title":"Invest New Drugs"},{"key":"8006_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bcp.2016.02.005","volume":"106","author":"L Aragoneses-Fenoll","year":"2016","unstructured":"Aragoneses-Fenoll L, et al. ETP-46321, a dual p110\u03b1\/\u03b4 class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis. Biochem Pharmacol. 2016;106:56\u201369.","journal-title":"Biochem Pharmacol"},{"key":"8006_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8006_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"8006_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8006_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"8006_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","volume":"12","author":"G Lei","year":"2021","unstructured":"Lei G, Mao C, Yan Y, Zhuang L, Gan B. Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. 2021;12:836\u201357.","journal-title":"Protein Cell"},{"key":"8006_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/ijms24010449","volume":"24","author":"L Rochette","year":"2022","unstructured":"Rochette L, et al. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. Int J Mol Sci. 2022;24:449.","journal-title":"Int J Mol Sci"},{"key":"8006_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00011-022-01672-1","volume":"72","author":"L Deng","year":"2023","unstructured":"Deng L, et al. Molecular mechanisms of ferroptosis and relevance to inflammation. Inflamm Res. 2023;72:281\u201399.","journal-title":"Inflamm Res"},{"key":"8006_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41418-018-0173-9","volume":"26","author":"B Proneth","year":"2019","unstructured":"Proneth B, Conrad M. Ferroptosis and necroinflammation, a yet poorly explored link. Cell Death Differ. 2019;26:14\u201324.","journal-title":"Cell Death Differ"},{"key":"8006_CR33","doi-asserted-by":"publisher","first-page":"e20210518","DOI":"10.1084\/jem.20210518","volume":"218","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Ferroptosis in infection, inflammation, and immunity. J Exp Med. 2021;218:e20210518.","journal-title":"J Exp Med"},{"key":"8006_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12:34.","journal-title":"J Hematol Oncol"},{"key":"8006_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","volume":"31","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation. Cell Death Differ. 2024;31:53\u201364.","journal-title":"Cell Death Differ"},{"key":"8006_CR36","doi-asserted-by":"publisher","first-page":"102317","DOI":"10.1016\/j.redox.2022.102317","volume":"52","author":"S Ouyang","year":"2022","unstructured":"Ouyang S, et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022;52:102317.","journal-title":"Redox Biol"},{"key":"8006_CR37","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.3748\/wjg.v29.i40.5593","volume":"29","author":"Y-N Li","year":"2023","unstructured":"Li Y-N, et al. Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999\u20132023). World J Gastroenterol. 2023;29:5593\u2013617.","journal-title":"World J Gastroenterol"},{"key":"8006_CR38","doi-asserted-by":"publisher","first-page":"118513","DOI":"10.1016\/j.lfs.2020.118513","volume":"262","author":"S Fattahi","year":"2020","unstructured":"Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H. PI3K\/AKT\/mTOR signaling in gastric cancer: Epigenetics and beyond. Life Sci. 2020;262:118513.","journal-title":"Life Sci"},{"key":"8006_CR39","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1038\/s12276-023-01062-5","volume":"55","author":"X Ren","year":"2023","unstructured":"Ren X, et al. SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK\/ERK and PI3K\/AKT pathways. Exp Mol Med. 2023;55:1757\u201369.","journal-title":"Exp Mol Med"},{"key":"8006_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/ijms22010173","volume":"22","author":"D Miricescu","year":"2020","unstructured":"Miricescu D, et al. PI3K\/AKT\/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. Int J Mol Sci. 2020;22:173.","journal-title":"Int J Mol Sci"},{"key":"8006_CR41","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P. The PI3K\/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. Int J Biol Sci. 2024;20:3113\u201325.","journal-title":"Int J Biol Sci"},{"key":"8006_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2019.07.009","volume":"59","author":"AS Alzahrani","year":"2019","unstructured":"Alzahrani AS. PI3K\/Akt\/mTOR inhibitors in cancer: At the bench and bedside. Semin Cancer Biol. 2019;59:125\u201332.","journal-title":"Semin Cancer Biol"},{"key":"8006_CR43","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.3390\/ijms21124507","volume":"21","author":"BY Shorning","year":"2020","unstructured":"Shorning BY, Dass MS, Smalley MJ, Pearson HB. The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. Int J Mol Sci. 2020;21:4507.","journal-title":"Int J Mol Sci"},{"key":"8006_CR44","doi-asserted-by":"publisher","first-page":"109726","DOI":"10.1016\/j.biopha.2019.109726","volume":"122","author":"L Rong","year":"2020","unstructured":"Rong L, et al. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K\/Akt\/mTOR pathway. Biomed Pharmacother. 2020;122:109726.","journal-title":"Biomed Pharmacother"},{"key":"8006_CR45","doi-asserted-by":"publisher","first-page":"109443","DOI":"10.1016\/j.biopha.2019.109443","volume":"120","author":"L Wang","year":"2019","unstructured":"Wang L, Yang H, Wang C, Shi X, Li K. Rosmarinic acid inhibits proliferation and invasion of hepatocellular carcinoma cells SMMC 7721 via PI3K\/AKT\/mTOR signal pathway. Biomed Pharmacother. 2019;120:109443.","journal-title":"Biomed Pharmacother"},{"key":"8006_CR46","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.5455\/OVJ.2024.v14.i10.12","volume":"14","author":"AB Achmad","year":"2024","unstructured":"Achmad AB, et al. Stem bark ethanolic extract of Pinus merkusii induces caspase 9-mediated apoptosis in HeLa cells. Open Vet J. 2024;14:2628\u201333.","journal-title":"Open Vet J"},{"key":"8006_CR47","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42:513\u201334.","journal-title":"Cancer Cell"},{"key":"8006_CR48","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1016\/j.molcel.2023.10.042","volume":"83","author":"W Zhang","year":"2023","unstructured":"Zhang W, et al. SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Mol Cell. 2023;83:4352\u2013e43698.","journal-title":"Mol Cell"},{"key":"8006_CR49","doi-asserted-by":"publisher","first-page":"188890","DOI":"10.1016\/j.bbcan.2023.188890","volume":"1878","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W. GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer. 2023;1878:188890.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8006_CR50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620.","journal-title":"Protein Cell"},{"key":"8006_CR51","doi-asserted-by":"publisher","first-page":"e04192","DOI":"10.1002\/advs.202504192","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. Ezetimibe Engineered L14-8 Suppresses Advanced Prostate Cancer by Activating PLK1\/TP53-SAT1-Induced Ferroptosis. Adv Sci (Weinh). 2025;12:e04192.","journal-title":"Adv Sci (Weinh)"},{"key":"8006_CR52","doi-asserted-by":"publisher","first-page":"114196","DOI":"10.1016\/j.addr.2022.114196","volume":"184","author":"ML Pardi","year":"2022","unstructured":"Pardi ML, Wu J, Kawasaki S, Saito H. Synthetic RNA-based post-transcriptional expression control methods and genetic circuits. Adv Drug Deliv Rev. 2022;184:114196.","journal-title":"Adv Drug Deliv Rev"},{"key":"8006_CR53","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/his.14555","volume":"80","author":"J Kalvala","year":"2022","unstructured":"Kalvala J, Parks RM, Green AR, Cheung K-L. Concordance between core needle biopsy and surgical excision specimens for Ki-67 in breast cancer - a systematic review of the literature. Histopathology. 2022;80:468\u201384.","journal-title":"Histopathology"},{"key":"8006_CR54","doi-asserted-by":"publisher","first-page":"141817","DOI":"10.1016\/j.ijbiomac.2025.141817","volume":"306","author":"B Li","year":"2025","unstructured":"Li B, et al. Long non-coding RNA LINC01232 promotes malignancy of prostate cancer through regulation of miR-181a-5p\/IRS2 pathway: Ki-67 protein molecular structure and function. Int J Biol Macromol. 2025;306:141817.","journal-title":"Int J Biol Macromol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08006-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08006-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08006-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:44:04Z","timestamp":1777002244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08006-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8006"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08006-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving animals adhered to the National Institutes of Health guidelines and were authorized by the Animal Care and Use Committee of Qilu Hospital of Shandong University (Certification No. KYDWLL-202431).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"581"}}